Humacyte, Inc. - 10-Q Filing

Humacyte, Inc. reports quarterly financial results including significant R&D and G&A expenses alongside complex derivative liabilities from financing activities.

SEC EDGAR ·

Tickers: $HUMA

Read the full article at SEC EDGAR

More Regulatory news